跳至主要内容
临床试验/NCT02026856
NCT02026856已完成不适用

Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis

Pavol Jozef Safarik University1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2013年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4
试验地点
1
主要终点
mortality

研究概览

简要总结

This study looked at parenteral administration of selenium to septic patients and subsequently monitored dynamic changes of selected activities of antioxidant enzymes and the development of clinical status.

详细描述

Patients will be divided into two groups. Se-group who received selenium supplementation during hospitalization in the form of sodium selenite pentahydrate at 750 mg/day for 6 days immediately after admission to our department (1000 mg of sodium selenite pentahydrate = 333 micrograms of selenium) (Selenase, Vivax; selenium hereinafter).

The placebo group will receive continuous saline NaCl 50 ml/day for 6 days as a continuous infusion (excluding additional infusion therapy). Patients will be further divided into subgroups according to OI on the day of admission to ICU. The oxygenation index (OI) PaO2/FiO2 (partial pressure of oxygen in arterial blood/ fraction of inspired oxygen) ratio in patients will be calculated daily.

The determination of biochemical and hematological parameters of blood samples will be as a part of the routine diagnostic methods. Data collection for the Se-AOX study will be performed at two-day intervals: T1 (1st-2nd day), T2 (3rd-4th day) and T3 (5th-6th day). Kinetic methods for estimating the activities of glutathione peroxidase (GPx, E.C. 1.11.1.9), glutathione reductase (GR, E.C.1.6.4.2) will be performed using a kit (Sigma-Aldrich, Germany) and that of superoxide dismutase (SOD, E.C. 1.15.1.1) by means of the SOD-Assay Kit-WST (Fluka, Japan) following the user manual provided.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sepsis, severe sepsis or septic shock, APACHE II score between 19 and 24 points after admission

排除标准

  • mechanical ventilation for less than 24h, neuromuscular disease and terminal illness were also excluding criteria

研究组 & 干预措施

Se-OI> 200

patients who received form of sodium selenite pentahydrate at 750 mg/day for 6 days immediately after admission to our department (1000 mg of sodium selenite pentahydrate = 333 micrograms of selenium) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/ fraction of inspired oxygen) was higher than 200

干预措施: sodium selenite pentahydrate (Drug)

Se-OI <200

patients who received form of sodium selenite pentahydrate at 750 mg/day for 6 days immediately after admission to our department (1000 mg of sodium selenite pentahydrate = 333 micrograms of selenium) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/ fraction of inspired oxygen) was lower than 200

干预措施: sodium selenite pentahydrate (Drug)

Placebo-OI> 200

patients who received continuous saline NaCl 50 ml/day for 6 days as a continuous infusion (excluding additional infusion therapy) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/ fraction of inspired oxygen) was higher than 200

干预措施: placebo - continuous saline NaCl 50 ml (Other)

Placebo-OI <200

patients who who received continuous saline NaCl 50 ml/day for 6 days as a continuous infusion (excluding additional infusion therapy) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/ fraction of inspired oxygen) was lower than 200

干预措施: placebo - continuous saline NaCl 50 ml (Other)

结局指标

主要结局

mortality

时间窗: 2 years

次要结局

  • The oxygenation index(2 years)

研究者

发起方
Pavol Jozef Safarik University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kočan Ladislav

MD PhD

Pavol Jozef Safarik University

研究点 (1)

Loading locations...

相似试验